![Tanja Ouimet](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Tanja Ouimet is currently the Chief Operating Officer & Director-Clinical Devt at Pharmaleads SA. She started this position in 2021.
Prior to her current role, she obtained a doctorate degree from the University of Montréal.
Aktive Positionen von Tanja Ouimet
Unternehmen | Position | Beginn |
---|---|---|
Pharmaleads SA
![]() Pharmaleads SA Pharmaceuticals: MajorHealth Technology Pharmaleads SA specializes in the detection, inhibition and modulation of proteases involved in human diseases. It designs and develops analgesic drugs with the aim to revolutionize the treatment of severe pain, with no side effects. The firm's products include high fluorescence substrates for proteases, substrates for BoNT quantification, and EzyBot, a field kit for botulinum toxin detection. The company was founded in 2000 by Bernard Roques and Marie-Claude Fournié-Zaluski and is headquartered in Paris, France. | Geschäftsführer | 06.01.2021 |
Ausbildung von Tanja Ouimet
University of Montréal | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Pharmaleads SA
![]() Pharmaleads SA Pharmaceuticals: MajorHealth Technology Pharmaleads SA specializes in the detection, inhibition and modulation of proteases involved in human diseases. It designs and develops analgesic drugs with the aim to revolutionize the treatment of severe pain, with no side effects. The firm's products include high fluorescence substrates for proteases, substrates for BoNT quantification, and EzyBot, a field kit for botulinum toxin detection. The company was founded in 2000 by Bernard Roques and Marie-Claude Fournié-Zaluski and is headquartered in Paris, France. | Health Technology |